Contact Us Locations About Products Pipeline Partnering Patients Investors & News Careers Leadership About Us Mission Leadership Transparency Reporting Working In the Best Interest of Patients We were founded in 2009 and our leadership team brings significant expertise in oncology drug development and commercialization to Clovis. Management Team Ann Bozeman Executive Vice President of Human Resources Paul E. Gross Executive Vice President and General Counsel Dr. Thomas Fuglsang Harding Executive Vice President and Chief Scientific Officer Gillian C. Ivers-Read Executive Vice President and Chief Regulatory Officer Patrick J. Mahaffy President and Chief Executive Officer; Director Daniel W. Muehl Executive Vice President and Chief Financial Officer Dr. Lindsey Rolfe Executive Vice President of Clinical Development and Pharmacovigilance and Chief Medical Officer Board of Directors Brian G. Atwood Director Robert W. Azelby Director James C. Blair, PhD Director Richard A. Fair Director Keith T. Flaherty, M.D. Director Ginger L. Graham Board Chair; Director Paul H. Klingenstein Director Patrick J. Mahaffy President and Chief Executive Officer; Director Edward J. McKinley Director Ronit Simantov, M.D. Director Dr. Thorlef Spickschen Director About Pipeline Patients Investors & News Careers Contact Us Privacy Policy Cookie Policy Terms Sitemap COPYRIGHT © 2021 BY CLOVIS ONCOLOGY, ALL RIGHTS RESERVED. By using this website without changing your cookie settings, you agree to our use of cookies. For more information on how we use cookies, please see our Cookie Policy and Privacy Policy. By clicking Accept you consent to our use of cookies. Accept